Highland Capital Management Fund Advisors, L.P. Amicus Therapeutics, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $494,832 - $670,345	-56,617 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $5,823 - $15,103	-633 Reduced 1.11%	56,617 $559,000
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $108,920 - $134,270	-8,450 Reduced 12.86%	57,250 $808,000
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $526,914 - $870,525	65,700 New	65,700 $527,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$260 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$253 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$220 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$216 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$209 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account